Hemoglobin compositions

Details for Australian Patent Application No. 2010258752 (hide)

Owner Prolong Pharmaceuticals, LLC

Inventors Abuchowski, Abraham; Sloshberg, Steven; O'Hare, Keith

Agent Allens Arthur Robinson

Pub. Number AU-A-2010258752

PCT Pub. Number WO2010/144629

Priority 61/185,547 09.06.09 US

Filing date 9 June 2010

Wipo publication date 16 December 2010

International Classifications

A61K 38/42 (2006.01) Medicinal preparations containing peptides

A61K 47/18 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

12 January 2012 PCT application entered the National Phase

  PCT publication WO2010/144629 Priority application(s): WO2010/144629

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010258754-Narrow lined modular flooring assemblies

2010258751-Treatment of chronic obstructive pulmonary disease with nebulized beta 2-agonist or combined nebulized beta 2-agonist and anticholinergic administration